Treeline Partners With Roche to Evaluate TLN-121 in Lymphoma
WATERTOWN, Mass., September 2, 2026 Treeline Biosciences, Inc. announced a clinical trial collaboration and supply agreement with Roche to...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
WATERTOWN, Mass., September 2, 2026 Treeline Biosciences, Inc. announced a clinical trial collaboration and supply agreement with Roche to...
AUSTIN, Texas, September 1, 2026 Natera announced publication of new clinical data in Blood Neoplasia supporting the prognostic and...
REDWOOD CITY, Calif., September 1, 2026 Adicet Bio announced completion of the last patient visit for the planned Phase...
CAMBRIDGE, Mass., U.S., Aug 28, 2026 CREATE Medicines, Inc. announced a strategic research and development collaboration and license agreement...
China & Singapore, August 13, 2026 IASO Biotechnology has completed the acquisition of MediSix Therapeutics, a Singapore-based immune cell...
ST. PAUL, Minnesota, August 11, 2026 Egg Medical, Inc., a medical technology company focused on radiation protection for healthcare...
WALNUT CREEK, California & SHANGHAI, China, August 11, 2026 Dark Horse Consulting Group (DHCG), a life sciences consulting organization...
San Diego, California, August 5, 2026 NueCell Bio has officially launched as a specialized cell therapy science and development...
DALLAS, Texas & PRINCETON, N.J. | June 19, 2026 Telos Biotech, Inc. has announced a strategic evaluation collaboration with...
BOSTON, Mass., May 8, 2026 Ensoma announced the presentation of initial clinical safety data from the first participant dosed...
